ABCA1 and metabolic syndrome: Within this context, the ABCA1 genotype functions as a modifier of lipid burden and lipid-driven neurodegeneration: individuals carrying disadvantageous ABCA1 variants in the presence of dyslipidemia are at increased risk of cholesterol-induced neuronal pathology [18,19,20].